Overview The past week brought important signals on continental immunization strategies (Africa), local manufacturing (South Africa, India), next generation COVID-19 and mucosal vaccines (Europe, Asia–Pacific), and politically driven shifts in vaccine policy (USA). Shigella and other enteric vaccines continue to gain momentum in the pipeline, even as no major new human vaccines were licensed. Africa Africa CDC moves toward a Continental Immunization Strategy Africa CDC issued a communiqué confirming work toward a Continental Immunization Strategy (CIS) aimed at strengthening routine immunization systems, closing equity gaps, and aligning with Immunization Agenda 2030. Reported points: Coverage gap: DTP3 coverage remains in the mid 70% range, significantly below the 90% IA2030 target. Focus areas: Zero-dose and under-immunized children, supply chain and data systems, and sustainable domestic financing. For vaccinating physicians and program managers, CIS foreshadows: More harmonized continental priorities (e.g., catch-up campaigns, HPV introduction, second year of life vaccines). Potentially greater pressure on countries to reduce sub-national inequities and report more granular...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
